Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
Tang LJ, Sun DQ, Song SJ, Yip TC, Wong GL, Zhu PW, Chen SD, Karsdal M, Leeming DJ, Jiang P, Wang C, Chen Q, Byrne CD, Targher G, Eslam M, George J, Wong VW, Zheng MH.
Tang LJ, et al.
Liver Int. 2024 May;44(5):1129-1141. doi: 10.1111/liv.15878. Epub 2024 Mar 1.
Liver Int. 2024.
PMID: 38426611